Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Aortoiliac Occlusive Disease

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Aortoiliac Occlusive Disease

Ali Kimyaghalam et al.
Free Books & Documents

Excerpt

Aortoiliac occlusive disease (AIOD), is a variant of peripheral artery disease (PAD) that affects the infrarenal aorta and iliac arteries, obstructing blood flow to distal organs through narrowed arterial lumens or embolization of plaques. Like other arterial diseases, this condition can present a wide range of symptoms, from asymptomatic cases to limb-threatening emergencies. For many patients, collateral circulation can be sufficient to manage symptoms nonoperatively. However, obstructive lesions are commonly found in the infrarenal aorta, common iliac artery, internal iliac (hypogastric) artery, external iliac artery, or combinations of these vessels.

Recognizing the numerous risk factors for AIOD allows clinicians to implement medical therapies that alleviate symptoms and extend patient survival. The advent of prosthetic graft materials in the 1960s revolutionized the surgical treatment of AIOD, offering a viable solution for patients with significant aortic and iliac occlusions. This review will examine the pathophysiology, clinical manifestations, diagnostic approaches, and contemporary management options, focusing on surgical and endovascular interventions to improve outcomes in patients with AIOD.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Ali Kimyaghalam declares no relevant financial relationships with ineligible companies.

Disclosure: Nicholas Fitzpatrick declares no relevant financial relationships with ineligible companies.

Disclosure: Yusuf Khan declares no relevant financial relationships with ineligible companies.

References

    1. Frederick M, Newman J, Kohlwes J. Leriche syndrome. J Gen Intern Med. 2010 Oct;25(10):1102-4. - PMC - PubMed
    1. Qi Y, Yang L, Zhang H, Liang E, Song L, Cai J, Jiang X, Zou Y, Qian H, Wu H, Zhou X, Hui R, Zheng D. The presentation and management of hypertension in a large cohort of Takayasu arteritis. Clin Rheumatol. 2018 Oct;37(10):2781-2788. - PubMed
    1. Chacko S, Joseph G, Thomson V, George P, George O, Danda D. Carbon dioxide Angiography-Guided Renal-Related Interventions in Patients with Takayasu Arteritis and Renal Insufficiency. Cardiovasc Intervent Radiol. 2018 Jul;41(7):998-1007. - PMC - PubMed
    1. Berger JS, Hochman J, Lobach I, Adelman MA, Riles TS, Rockman CB. Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. J Vasc Surg. 2013 Sep;58(3):673-81.e1. - PubMed
    1. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004 Jan;172(1):95-105. - PubMed

Publication types

LinkOut - more resources